News > ICMR, Serum Institute Of India Complete Enrolment Of Phase 3 Clinical Trials For Covishield
ICMR, Serum Institute Of India Complete Enrolment Of Phase 3 Clinical Trials For Covishield
Swachhindia | 12/11/2020 03:55 PM | Click to read full article
The Serum Institute of India (SII) and Indian Council of Medical Research (ICMR) have announced the completion of enrolment of phase 3 clinical trials for COVISHIELD in India. Commenting on the association, Adar Poonawalla, CEO of Serum Institute of India, said,
“ICMR has played a huge role in coming forward and strengthening India’s fight against COVID-19. The collaboration will further aid us in putting India at the forefront of developing an immunogenic and efficacious vaccine."